Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric M Reiman

Showing results (321-330 of 434) with videos related to

Pageof 44
Sort By:
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2022
Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's diseaseDavid Aguillon, Stephanie Langella, Yinghua Chen, et al.
Neuro-Degenerative Diseases|November 3, 2007
Sorl1 as an Alzheimer's disease predisposition gene?Jennifer A Webster, Amanda J Myers, John V Pearson, et al.
The Lancet. Neurology|November 10, 2012
Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional studyAdam S Fleisher, Kewei Chen, Yakeel T Quiroz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2026
Advancing biomarker development for chronic traumatic encephalopathy: Summary and recommendations from the 2025 Leon Thal SummitCharles Bernick, Brooke Conway Kleven, Michael L Alosco, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
JAMA Neurology|January 13, 2015
Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional studyAdam S Fleisher, Kewei Chen, Yakeel T Quiroz, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's diseaseSofia Tzimopoulou, Vincent J Cunningham, Thomas E Nichols, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 6, 2023
Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's diseaseClara Vila-Castelar, Yinghua Chen, Stephanie Langella, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJenna R Groh, Annalise E Miner, Chad William Farris, et al.
Alzheimer'S Research & Therapy|October 1, 2024
Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's diseaseStephanie Langella, Kyra Bonta, Yinghua Chen, et al.
Pageof 44

Showing results (321-330 of 434) with videos related to

Sort By:
Pageof 44
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 26, 2022
Plasma p-tau217 predicts in vivo brain pathology and cognition in autosomal dominant Alzheimer's diseaseDavid Aguillon, Stephanie Langella, Yinghua Chen, et al.
Neuro-Degenerative Diseases|November 3, 2007
Sorl1 as an Alzheimer's disease predisposition gene?Jennifer A Webster, Amanda J Myers, John V Pearson, et al.
The Lancet. Neurology|November 10, 2012
Florbetapir PET analysis of amyloid-β deposition in the presenilin 1 E280A autosomal dominant Alzheimer's disease kindred: a cross-sectional studyAdam S Fleisher, Kewei Chen, Yakeel T Quiroz, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|May 13, 2026
Advancing biomarker development for chronic traumatic encephalopathy: Summary and recommendations from the 2025 Leon Thal SummitCharles Bernick, Brooke Conway Kleven, Michael L Alosco, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|April 26, 2011
Toward defining the preclinical stages of Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's diseaseReisa A Sperling, Paul S Aisen, Laurel A Beckett, et al.
JAMA Neurology|January 13, 2015
Associations between biomarkers and age in the presenilin 1 E280A autosomal dominant Alzheimer disease kindred: a cross-sectional studyAdam S Fleisher, Kewei Chen, Yakeel T Quiroz, et al.
Journal of Alzheimer'S Disease : JAD|October 9, 2010
A multi-center randomized proof-of-concept clinical trial applying [¹⁸F]FDG-PET for evaluation of metabolic therapy with rosiglitazone XR in mild to moderate Alzheimer's diseaseSofia Tzimopoulou, Vincent J Cunningham, Thomas E Nichols, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|June 6, 2023
Sex differences in blood biomarkers and cognitive performance in individuals with autosomal dominant Alzheimer's diseaseClara Vila-Castelar, Yinghua Chen, Stephanie Langella, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 24, 2025
BiomarkersJenna R Groh, Annalise E Miner, Chad William Farris, et al.
Alzheimer'S Research & Therapy|October 1, 2024
Impact of APOE ε4 and ε2 on plasma neurofilament light chain and cognition in autosomal dominant Alzheimer's diseaseStephanie Langella, Kyra Bonta, Yinghua Chen, et al.
Pageof 44